How Strong Is Tylenol 3 Compared to Other Painkillers?

Tylenol 3 sits at the lower end of prescription opioid painkillers, and clinical trials consistently show it performs about as well as over-the-counter alternatives like ibuprofen for most acute pain. Each tablet combines 300 mg of acetaminophen with 30 mg of codeine, and while codeine is technically an opioid, its pain-relieving power depends on a liver enzyme that varies wildly from person to person. The result is a drug whose reputation as a “step up” from regular Tylenol or ibuprofen often overshoots its actual performance in the research.

What Tylenol 3 Actually Is

Tylenol 3 (also written as Tylenol No. 3 or Tylenol #3) is a combination of acetaminophen and codeine phosphate. The acetaminophen portion works the same way as a regular Tylenol tablet, reducing pain through pathways in the central nervous system. The codeine portion is an opioid, but it isn’t active in its original form. Your liver has to convert codeine into morphine using a specific enzyme called CYP2D6 before it can bind to opioid receptors and provide that additional layer of pain relief.¹ That conversion step is the reason Tylenol 3’s strength is harder to pin down than most drugs. How much morphine your body actually produces from a dose of codeine depends on your individual genetics, and we’ll return to why that matters in a later section.

How Codeine Performs on Its Own

To understand where Tylenol 3 falls on the painkiller spectrum, it helps to isolate the codeine component. A Cochrane systematic review pooled data from 33 studies covering over 2,400 participants and found that 60 mg of codeine alone, which is double the dose in a single Tylenol 3 tablet, produced at least 50% pain relief in only about 26% of people, compared to 17% on placebo.² That translates to a number needed to treat of 12, meaning you’d have to give codeine to 12 people for one extra person to get meaningful relief beyond what a sugar pill provides. After dental surgery specifically, the numbers looked even worse. Those are not impressive figures for a drug that carries opioid-level side effects and addiction risk.

The saving grace of Tylenol 3 is the acetaminophen. Combining an opioid with a non-opioid painkiller genuinely works better than either drug alone. The acetaminophen does meaningful heavy lifting, and the codeine adds a modest opioid boost on top. Still, the codeine component by itself is one of the weakest opioids in clinical use, and that shapes every comparison that follows.

Tylenol 3 Versus Ibuprofen

This is where the evidence gets uncomfortable for anyone who assumes a prescription opioid must outperform something you can buy off the shelf. Multiple trials have directly compared Tylenol 3 to plain ibuprofen, and the results are remarkably consistent: ibuprofen matches or beats it, with fewer side effects.

A randomized trial of women experiencing pain after childbirth found that ibuprofen and acetaminophen with codeine had essentially identical analgesic properties over the first 24 hours. The mean pain rating was 3.4 for ibuprofen versus 3.3 for the codeine combination, and the number of doses patients needed was identical. Where the drugs diverged was side effects. Roughly 52% of women in the ibuprofen group experienced side effects, compared to about 72% in the acetaminophen-with-codeine group.³

A separate trial after outpatient surgery compared acetaminophen plus ibuprofen against Tylenol No. 3 and found a similar pattern. Pain scores throughout the recovery week were modestly lower in the ibuprofen group, and patient satisfaction told the story clearly: 83% of people taking the ibuprofen combination were satisfied with their pain management, compared to 64% on Tylenol 3. Side effects were more common with Tylenol 3 (57% versus 41%), and patients quit the codeine combination at a higher rate.⁴ So not only did Tylenol 3 fail to provide meaningfully better relief, it left people feeling worse overall.

Tylenol 3 Versus Hydrocodone Combinations

Hydrocodone (found in brand names like Vicodin and Norco) is generally considered a step above codeine in opioid potency. It’s one of the most commonly prescribed opioids in the United States, and many doctors reach for it when they feel an over-the-counter option won’t be enough. So how much stronger is it, really?

In an early trial comparing hydrocodone to codeine for acute musculoskeletal pain, researchers found that pain scores were not significantly different between the two drugs, though hydrocodone had fewer treatment failures, suggesting it may have a slight edge in reliability.⁵ A more recent randomized trial of patients discharged from the emergency department with extremity pain compared hydrocodone/acetaminophen directly against codeine/acetaminophen. Pain dropped by about 3.9 points on a 10-point scale in the hydrocodone group versus 3.5 points in the codeine group, a difference of just 0.4 points that was neither clinically meaningful nor statistically significant. Both medications cut pain scores by roughly half.⁶

That finding surprises people who think of hydrocodone as a much more powerful drug. In practice, for the kind of moderate acute pain that sends someone home from the ER, the difference between these two combination products is small enough that many patients wouldn’t notice it.

Tylenol 3 Versus Oxycodone Combinations

Oxycodone (found in Percocet when combined with acetaminophen, or OxyContin in extended-release form) is a clearly stronger opioid than codeine by any pharmacological measure. You might expect it to produce dramatically better pain relief. The clinical data, again, is more nuanced than the potency ranking would suggest.

A trial comparing oxycodone/acetaminophen to codeine/acetaminophen for short-term pain after emergency department discharge found that pain dropped by 4.5 points in the oxycodone group versus 4.2 in the codeine group, a nonsignificant difference of just 0.2 points. Roughly 66% achieved at least 50% pain relief on oxycodone compared to 61% on codeine, a gap that also wasn’t statistically significant. Side effects and patient satisfaction were similar between the two groups.⁷

A randomized trial of patients recovering from surgically managed fractures echoed this pattern. The mean daily pain score over the first week was 4.0 in the oxycodone group versus 4.5 in the codeine/acetaminophen group, a difference that did not reach statistical significance, despite the fact that patients in the oxycodone arm received roughly six times the opioid dose.⁸ Six times the opioid dose for a half-point improvement that didn’t even clear the bar for statistical significance. That ratio puts Tylenol 3’s performance in a different light. For many kinds of acute pain, the acetaminophen component is doing most of the work, and switching to a stronger opioid adds risk without a proportional gain in relief.

Why These Comparisons Keep Coming Out So Close

If codeine is genuinely weaker than hydrocodone or oxycodone on a milligram-for-milligram basis, why do the head-to-head trials show such small differences? A few things are happening at once. First, all of these combination products include acetaminophen (or ibuprofen), and that non-opioid ingredient provides a consistent baseline of pain relief regardless of which opioid is paired with it. As the opioid dose climbs, you’re stacking diminishing returns on top of a stable foundation. Second, acute pain in the moderate range has a ceiling effect: once pain is already cut in half, pushing it further requires disproportionately more drug. Third, stronger opioids bring stronger side effects like nausea and sedation, which can actually worsen a patient’s overall experience even if the raw pain number ticks down slightly.

The practical takeaway is that Tylenol 3 occupies an awkward middle ground. It’s barely stronger than ibuprofen for most acute pain scenarios, but it carries the side effects and regulatory burden of an opioid. Its main advantage over the over-the-counter option is limited to situations where anti-inflammatory drugs are contraindicated, such as certain bleeding risks or kidney problems, or when the combination of acetaminophen and an NSAID has already been tried and failed.

Your Genetics Can Make Codeine Useless or Dangerous

The CYP2D6 enzyme that converts codeine to morphine isn’t equally active in everyone. People generally fall into four categories based on their genetic makeup: poor metabolizers, intermediate metabolizers, extensive (normal) metabolizers, and ultrarapid metabolizers. Poor metabolizers produce very little morphine from codeine, which means Tylenol 3 barely works as an opioid for them. Ultrarapid metabolizers do the opposite: they convert codeine into morphine faster and in larger amounts than expected, which can lead to dangerously high morphine levels from a standard dose.⁹

How common are these extremes? It varies by ethnic background, but ultrarapid metabolizers are found across all populations at rates high enough to be a real clinical concern. Research on a diverse urban population confirmed that the rate of ultrarapid metabolizers is clinically significant and recommended a pharmacogenomic approach, essentially genetic testing before prescribing, to tailor drug selection and dosing.¹⁰ In practice, most people don’t get tested before receiving a Tylenol 3 prescription, which means a meaningful fraction of patients are either getting almost no opioid benefit or getting more than their doctor intended.

This genetic variability is unique to codeine and partially explains why the clinical trials show such mixed results. In any study group, some participants are poor metabolizers who aren’t really taking an opioid at all, while others are ultrarapid metabolizers getting a bigger hit than planned. That biological noise blurs the drug’s average performance and makes it less predictable than alternatives whose effects don’t depend on a single polymorphic enzyme.

Other Medications Can Block Codeine’s Effect

Even people with normal CYP2D6 genetics can have their codeine rendered ineffective if they’re taking another drug that inhibits the same enzyme. Several common medications do exactly that, including certain antidepressants like fluoxetine (Prozac) and paroxetine (Paxil), as well as the antihistamine diphenhydramine (Benadryl).

A large study found that patients taking codeine, hydrocodone, or tramadol who were also on a CYP2D6-inhibiting antidepressant had nearly double the rate of pain-related emergency department visits compared to those on antidepressants that don’t block the enzyme (about 3.3% versus 1.9%), with an adjusted odds ratio of 1.75.¹¹ In plain terms, the antidepressant was blocking the liver enzyme needed to activate the painkiller, so patients weren’t getting adequate relief and ended up back in the emergency room.

If you’ve ever felt like Tylenol 3 “doesn’t work” for you, and you take an SSRI antidepressant or regularly use diphenhydramine for allergies or sleep, this interaction is a likely explanation. Your doctor may not think to check for it unless you bring it up. Stronger opioids like oxycodone don’t rely on CYP2D6 for activation, which is one reason they can be more consistent, if not necessarily more appropriate, in patients on these medications.

Why Codeine Is No Longer Recommended for Children

One area where the genetic variability of codeine metabolism has had serious consequences is pediatrics. Children who are ultrarapid metabolizers can convert a standard dose of codeine into dangerously high levels of morphine, and several cases of severe respiratory depression and death in children prompted regulatory action. The FDA added a black box warning stating that codeine is contraindicated for pain management in children after tonsillectomy or adenoidectomy.¹²

This restriction has since broadened. Most pediatric guidelines now recommend against codeine use in children under 12 entirely, and caution against it in adolescents aged 12 to 18 who are obese or have conditions like obstructive sleep apnea that increase the risk of breathing problems. For families, the practical message is straightforward: if your child’s doctor prescribes Tylenol 3 or any codeine-containing product, it’s worth asking whether an alternative has been considered. Ibuprofen and acetaminophen together are now the standard first-line approach for most pediatric pain.

Where Tylenol 3 Still Has a Role

Given everything above, you might wonder why Tylenol 3 is still prescribed at all. The answer comes down to a few specific niches. For patients who cannot take NSAIDs due to kidney disease, gastrointestinal bleeding risk, or allergy, the codeine in Tylenol 3 provides a modest opioid addition to acetaminophen that can help with moderate pain when anti-inflammatory drugs are off the table. It also remains a common choice in countries and healthcare systems where access to other opioids is more tightly restricted or where codeine sits in a lower regulatory schedule than hydrocodone or oxycodone.

In some clinical contexts, the weakness of codeine is actually the point. A doctor prescribing Tylenol 3 for a few days after a minor procedure may be intentionally choosing the least potent opioid available, reasoning that a small boost over acetaminophen alone is enough and that the risk profile is lower than jumping straight to oxycodone. That logic makes sense only when the prescriber understands the patient’s metabolism and isn’t setting them up for treatment failure.

Tylenol 3 also carries a meaningful acetaminophen dose: 300 mg per tablet, with a typical dosing schedule of one to two tablets every four to six hours. At the higher end of that range, total daily acetaminophen can approach limits that stress the liver, particularly for people who drink alcohol regularly or take other acetaminophen-containing products without realizing it. That ceiling on acetaminophen effectively caps how many tablets you can safely take per day, which in turn caps the amount of codeine you receive. It’s a built-in governor that limits both the benefit and the harm, but only if patients are aware of it.